Cite
Howard D, Garcia-Parra J, Healey GD, et al. Antibody-drug conjugates and other nanomedicines: the frontier of gynaecological cancer treatment. Interface Focus. 2016;6(6):20160054doi: 10.1098/rsfs.2016.0054.
Howard, D., Garcia-Parra, J., Healey, G. D., Amakiri, C., Margarit, L., Francis, L. W., Gonzalez, D., & Conlan, R. S. (2016). Antibody-drug conjugates and other nanomedicines: the frontier of gynaecological cancer treatment. Interface focus, 6(6), 20160054. https://doi.org/10.1098/rsfs.2016.0054
Howard, David, et al. "Antibody-drug conjugates and other nanomedicines: the frontier of gynaecological cancer treatment." Interface focus vol. 6,6 (2016): 20160054. doi: https://doi.org/10.1098/rsfs.2016.0054
Howard D, Garcia-Parra J, Healey GD, Amakiri C, Margarit L, Francis LW, Gonzalez D, Conlan RS. Antibody-drug conjugates and other nanomedicines: the frontier of gynaecological cancer treatment. Interface Focus. 2016 Dec 06;6(6):20160054. doi: 10.1098/rsfs.2016.0054. PMID: 27920893; PMCID: PMC5071815.
Copy
Download .nbib